Stage · Series B–C
Recruiting for growth-stage life sciences companies.
Scaling team, approaching commercial inflection, building infrastructure. The first CCO, the head of people, the structured search cadence — all begin here.
- First CCO, first head of people, first VP Marketing
- Pre-launch readiness team architecture
- Investor and board-aligned C-suite searches
- Structured retained search at the senior+ level becomes the norm
Connected practice
How this work intersects the rest of the practice.
Frequently asked
Common questions, answered plainly.
- When is the right time to hire a CCO?
- Most biotechs miss this hire by 6–12 months. The right window is typically post-Phase II data, before Phase III readout — early enough to shape launch readiness, late enough to actually retain the candidate.
- Do you work with the board on these searches?
- Yes. C-suite searches at growth-stage often involve direct board / lead investor engagement. We run these with explicit communication discipline across founders, board, and lead investors.
- Can you support a head of people first hire?
- Yes — increasingly, growth-stage biotechs hire their first dedicated people leader between Series B and C. This is a high-impact first hire we work frequently.
Hiring at growth-stage?
We've staffed companies through this exact inflection. Tell us where you are and what's next.
